CYT-338
Cytovia Therapeutics
['flex']
bcbn feed: cytovia therapeutics presents antitumor activity of its cd38-targeting flex-nk cell engager antibody at eha 2022 congress: data supports further development of cyt-338 in relapsed/refractory ... #boston #biotech 
Boston Cambridge Biotech Networks: Building a community and providing news and events for the local life science industry. For jobs follow @bcbnjobs